Analyst Ratings For Strongbridge Biopharma (NASDAQ:SBBP)
Today, Cantor Fitzgerald reiterated its Buy rating on Strongbridge Biopharma (NASDAQ:SBBP) with a price target of $14.00.
Some recent analyst ratings include
- 3/12/2018-Cantor Fitzgerald Reiterated Rating of Buy.
- 1/18/2018-HC Wainwright Reiterated Rating of Buy.
- 8/10/2017-Oppenheimer initiated coverage with a Outperform rating.
- 12/28/2016-JMP Securities Reiterated Rating of Outperform.
Recent Trading Activity for Strongbridge Biopharma (NASDAQ:SBBP)
Shares of Strongbridge Biopharma closed the previous trading session at 7.42 down -0.33 4.29% with 7.25 shares trading hands.